ArticleCancer research communications2023
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A.
Open access · goldAbstract read
In one paragraph
Article in Cancer research communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 20 citations in OpenAlex.
- ATP-dependent chromatin remodelers in prostate cancer progression and therapeutic resistance.Endocrinology · 2026Review
- Integrated Transcriptomic Analysis Identifies Potential Biomarkers in Castration-Resistant Prostate Cancer.World journal of oncology · 2026Article
- TGBWDriver: A Cancer Driver Gene Identification Method Based on GraphSAGE and Bidirectional Weighted Feature Aggregation.International journal of molecular sciences · 2026Article
- Synthetic Modulators of the Vitamin D Receptor: From Structural Innovation to Disease-Specific Applications.Biomolecules · 2026Review
- Vitamin D deficiency alters prostate epithelial differentiation and increases prostate cancer aggressiveness in ex vivo and in vivo models.bioRxiv : the preprint server for biology · 2026Article
- Genomic Crosstalk Between Nuclear Receptors in Hormone-dependent Cancers.Endocrinology · 2025Review
- Vitamin D-related genetic variants and prostate cancer risk in Black men.Cancer epidemiology · 2025Article
- Article
- The role of ANLN in malignant tumors: pathogenesis, treatment resistance and targeted strategies.Frontiers in cell and developmental biology · 2025Review
- Racial disparity in prostate cancer: an outlook in genetic and molecular landscape.Cancer metastasis reviews · 2024Review
- Alternative splicing of BAZ1A in colorectal cancer disrupts the DNA damage response and increases chemosensitization.Cell death & disease · 2024Article
- ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer.Nucleic acids research · 2024Article
- The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men.Nature reviews. Urology · 2024Review
- Vitamin D and prostate cancer prevention.World journal of clinical oncology · 2024Article
- 1,25-Dihydroxyvitamin DBiology · 2024Article
- Epigenetic disruption of the RARγ complex impairs its function to bookmark AR enhancer interactions required for enzalutamide sensitivity in prostate cancer.bioRxiv : the preprint server for biology · 2024Article
- The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide.bioRxiv : the preprint server for biology · 2023Article
- ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer.bioRxiv : the preprint server for biology · 2023Article
- Vitamin D and Systems Biology.Nutrients · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors at 11 institutions in 3 countries.
Manjunath Siddappa *Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-9597-1410
Shahid Hussain *Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-5874-6732
Sajad A WaniPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-7593-1825
Jason WhiteDepartment of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, Alabama.ORCID 0000-0002-2725-5009
Hancong TangPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.ORCID 0000-0003-3986-0617
Jaimie S GrayPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-6326-9179
Hedieh JafariPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.ORCID 0000-0001-9129-2720
Hsu-Chang WuPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-1341-6182
Mark D LongDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0003-1120-8176
Isra ElhussinDepartment of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, Alabama.ORCID 0000-0002-4141-8783
Balasubramanyam KaranamDepartment of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, Alabama.ORCID 0000-0002-0782-2539
Honghe WangDepartment of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, Alabama.ORCID 0000-0002-1401-4476
Rebecca MorganSchool of Biological Sciences, Institute for Global Food Security, Queen's University Belfast, Belfast, United Kingdom.ORCID 0000-0003-3589-9143
Gary HardimanSchool of Biological Sciences, Institute for Global Food Security, Queen's University Belfast, Belfast, United Kingdom.ORCID 0000-0003-4558-0400
Isaacson B AdelaniDepartment of Biochemistry, Covenant University, Ota, Ogun State, Nigeria.ORCID 0000-0002-2421-5271
Solomon O RotimiDepartment of Biochemistry, Covenant University, Ota, Ogun State, Nigeria.ORCID 0000-0002-3678-9977
Adam R MurphyDepartment of Urology, Northwestern Medicine, Chicago, Illinois.ORCID 0000-0001-9977-3473
Larisa NonnDepartment of Pathology, University of Illinois at Chicago, Chicago, Illinois.ORCID 0000-0002-0852-7726
Melissa B DavisDepartment of Surgery, Weill Cornell Medicine, New York City, New York.ORCID 0000-0002-6124-6923
Rick A KittlesDivision of Health Equities, Department of Population Sciences, City of Hope, Duarte, California.ORCID 0000-0002-5004-4437
Chanita Hughes HalbertDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, California.ORCID 0000-0002-0103-6916
Lara E Sucheston-CampbellDivision of Pharmacy Practice and Science, College of Pharmacy, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-2687-3112
Clayton YatesDepartment of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, Alabama.ORCID 0000-0001-5420-9852
Moray J CampbellPharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio.ORCID 0000-0002-3355-0928
The Ohio State University · USTuskegee University · USCovenant University · NGQueen's University Belfast · GBCity of Hope · USCornell University · USJohns Hopkins University · USNorthwestern Medicine · USRoswell Park Comprehensive Cancer Center · USUniversity of Illinois Chicago · USUniversity of Southern California · US
Funding
Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3MTuskegee University Center for Biomedical Research/ Research Centers at Minority InstitutionsU54MD007585 · NIMHD · TUSKEGEE UNIVERSITY · PI Jason Anthony White · 2017 to 2026
$29.4MResearch Education CoreU54CA118623 · NCI · TUSKEGEE UNIVERSITY · PI Vivian L Carter, TIMOTHY TURNER · 2005 to 2026
$20.2MPilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6MSociobiological Responses to Stress in Prostate Cancer SurvivorsU54MD010706 · NIMHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ETHIER, STEPHEN P., HUGHES-HALBERT, CHANITA A. · 2016 to 2020
$8.0MNCI NIH HHS P30 CA016058NCI NIH HHS U54 CA118623NIEHS NIH HHS P30 ES027792NIMHD NIH HHS U54 MD007585NIMHD NIH HHS U54 MD010706
Abstract
African American (AA) prostate cancer associates with vitamin D Significance: Our study identified that genomic ancestry drives the VDR complex composition, genomic distribution, and transcriptional function, and is disrupted by BAZ1A and illustrates a novel driver for AA prostate cancer.
Indexed as
Prostatic NeoplasmsReceptors, CalcitriolBlack or African AmericanBromodomain Containing ProteinsChromatinChromosomal Proteins, Non-HistoneHumansMaleTranscriptomeBAZ1A protein, humanBromodomain Containing ProteinsChromatinChromosomal Proteins, Non-HistoneReceptors, Calcitriol
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.